Lv3
210 积分 2023-06-23 加入
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
2天前
已完结
Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke
1个月前
已完结
Real‐World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study
1个月前
已完结
Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn’s disease: real-life cohort from a tertiary referral center
1个月前
已完结
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score–Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study
1个月前
已完结
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease
1个月前
已完结
A nomogram for the prediction of co-infection in MDA5 dermatomyositis: A rapid clinical assessment model
1个月前
已完结
MICDnet: Multimodal information processing networks for Crohn’s disease diagnosis
2个月前
已完结
Comparative efficacy and safety of combination therapy with infliximab for Crohn’s disease: a systematic review and network meta-analysis
2个月前
已完结
High Body Mass Index and Response to Anti-Tumor Necrosis Factor Therapy in Pediatric Crohn’s Disease
2个月前
已完结
皖公网安备34019202002308
